GlassScriptPhysician profile
James David Crampton
NPI 1346216272
$5,910.64
in general payments reported to CMS, 2019-2025
34 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $1,215 · 2023: $1,378 · 2024: $1,748 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,574.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $901.54 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $855.35 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $600.07 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $407.94 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Amgen INC. | $400.55 | 2022-2025 | Evenity, Repatha, Krystexxa |
| Abbvie INC. | $395.51 | 2022-2025 | |
| Pfizer INC. | $326.08 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $269.67 | 2022-2024 | |
| Glaxosmithkline, LLC. | $239.32 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $208.30 | 2022-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $138.58 | 2022-2025 | Trintellix, Gattex |
| Exact Sciences Corporation | $136.78 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $121.18 | 2021 | |
| Paratek Pharmaceuticals, INC. | $89.66 | 2022-2024 | Nuzyra |
| Sanofi-Aventis U.S. LLC | $89.38 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $87.19 | 2022-2024 | Freestyle Libre 3 |
| Supernus Pharmaceuticals, INC. | $82.63 | 2022-2023 | Qelbree |
| Aimmune Therapeutics, INC. | $70.60 | 2023-2025 | Zenpep |
| Otsuka America Pharmaceutical, INC. | $69.45 | 2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.25 | 2022-2025 | Tradjenta, Jardiance |
| Inspire Medical Systems, INC. | $44.50 | 2025 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $41.08 | 2022-2023 | Camzyos |
| Astellas Pharma US INC | $38.46 | 2023-2024 | Myrbetriq, Veozah |
| Dexcom, INC. | $32.40 | 2025 | Dexcom G6 Transmitter |
| Nestle Healthcare Nutrition INC. | $28.32 | 2023 | |
| Amneal Pharmaceuticals LLC | $23.87 | 2023 | Unithroid |
| Sanofi Pasteur INC. | $23.10 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.56 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.64 | 2024 | Caplyta |
| Ortho-Clinical Diagnostics, INC. | $18.72 | 2024 | Sofia |
| Actelion Pharmaceuticals US, INC. | $16.66 | 2025 | Uptravi, Opsumit |
| Daiichi Sankyo INC. | $16.06 | 2022 | |
| Nevro Corp. | $15.51 | 2024 | Senza |
| Inari Medical, INC. | $13.73 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Crampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.